Chris Tovey visits the Management School for MBA Masterclass

Published on

Chris Tovey, Chief Operating Officer at GW Pharmaceuticals, visited the Management School as the next guest speaker for the MBA masterclass series.

Chris has over 25 years experience in the pharmaceutical industry. Prior to joining GW Pharmaceuticals, he was at UCB Pharmaceuticals from 2006 to 2012 where his most recent role was the Vice President of Global Marketing Operations where he was responsible for worldwide marketing activities on a portfolio of UCB products generating over €2.0 billion in annual sales. Previous experience and roles at UCB included Managing Director Greece and Cyprus, and leader of all UCB activities on the orphan narcotic medication Xyrem, used in the treatment of narcolepsy.

Chris also previously spent 18 years at GlaxoSmithKline plc in senior commercial roles in both the European and U.K. organizations. These roles included Director Commercial Strategy Distribution Europe, Director European Vaccine Therapy Director Commercial Development U.K., Director Vaccines Business Unit U.K. and Business Unit Manager Oncology U.K. While at GSK, he worked across a wide range of therapeutic areas including infectious diseases, neurology, oncology, diabetes, respiratory, and immunology.

Chris also holds a BSc. degree in Marine Biology from the University of Liverpool.

During his talk he spoke about the importance of passion in finding a future career and advised students to ensure they have a healthy work life balance.